Study Stopped
Stopped by the Sponsor due to their change in product development priorities.
Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings
1 other identifier
interventional
6
1 country
1
Brief Summary
Burn injury is the result of an energy transfer that destroys the skin and adjacent tissues. Partial thickness burn wounds are painful and difficult to manage. The aim of burn treatment in partial thickness burns is to promote rapid wound healing, decrease pain, protect wound from infections, minimize scar formation and functional impairment In recent years, there are progressive development of new dressing material with a variety of option for depth adapted wound management. Many wound dressings are available for superficial and partial thickness burns. Hydrogel based wound dressing provides good biocompatibility with the skin and mucosa and promotes hydration of the wound bed. Aluminaid wound dressings is a hydrogel based wound dressing that is integrated with aluminium that was designed to reduce acute pain in the treatment of superficial and partical thickness burn injuries. Up to date, no evidence regarding integrated with aluminium sheet in hydrogel based wound dressings for the use in partial thickness burns. Therefore this trials is aimed to evaluate the efficacy and safety of Aluminaid versus Hydrogel for the treatment of partial thickness burns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 12, 2017
CompletedFirst Posted
Study publicly available on registry
June 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2018
CompletedMarch 12, 2018
March 1, 2018
1 year
June 12, 2017
March 9, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Wound healing
Wound healing as determine by the time of complete re-epithelization of the study area, in days.
Up to 21 days
Secondary Outcomes (4)
Erythema
at the time of admission up to 30 minutes
Bullae
at the time of admission up to 30 minutes
Pain score
At the time of admission up to 30 minutes and 1st week of follow up
Adverse events
At the time of admission up to 21 days of follow up
Study Arms (2)
Aluminaid
EXPERIMENTALTreatment group: Aluminaid wound dressing
Hydrogel
ACTIVE COMPARATORHydrogel wound dressing (Trademark: Burnshield)
Interventions
Eligibility Criteria
You may qualify if:
- Adults and children of 12 - 65 years old
- Partial thickness thermal burns of minimally 1% total body surface area (TBSA)
- Admission of less than 4 hours of burn injury
- Patients/legal guardian still have the ability to undergo examinations and give written informed consent.
You may not qualify if:
- Total body surface area (TBSA) of more than 20%
- Burns caused by chemicals, electricity or radiation
- Superficial and partial thickness burns located on the faces, palms, soles, genitalia, perineum and joint areas
- Superficial and partial thickness burns with compartment syndrome
- Superficial and partial thickness burns with a history of life-threatening trauma
- Had concomitant disease such as diabetes mellitus
- Signs of infected burns
- Patients with known allergies to product containing aluminium, hydrogel or a history of contact dermatitis
- Other conditions which according to the investigator's judgment are not appropriate to be included in the study.
- Treated with other agents before attend to clinic (oil, tooth paste, betadine, rivanol etc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Melva Louisalead
Study Sites (1)
Clinic of Clinical Research Supporting Unit
Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia
Related Publications (8)
Grippaudo FR, Carini L, Baldini R. Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns. 2010 Sep;36(6):871-5. doi: 10.1016/j.burns.2009.10.021. Epub 2010 Jan 15.
PMID: 20079572BACKGROUNDCancio LC, Lundy JB, Sheridan RL. Evolving changes in the management of burns and environmental injuries. Surg Clin North Am. 2012 Aug;92(4):959-86, ix. doi: 10.1016/j.suc.2012.06.002.
PMID: 22850157BACKGROUNDHettiaratchy S, Dziewulski P. ABC of burns: pathophysiology and types of burns. BMJ. 2004 Jun 12;328(7453):1427-9. doi: 10.1136/bmj.328.7453.1427. No abstract available.
PMID: 15191982BACKGROUNDLars PK, Giretzlehner M, Trop M, Parvizi D, Spendel S, Schintler M, Justich I, Wiedner M, Laback C, Lumenta DB. The properties of the "ideal" donor site dressing: results of a worldwide online survey. Ann Burns Fire Disasters. 2013 Sep 30;26(3):136-41.
PMID: 24563639BACKGROUNDRowan MP, Cancio LC, Elster EA, Burmeister DM, Rose LF, Natesan S, Chan RK, Christy RJ, Chung KK. Burn wound healing and treatment: review and advancements. Crit Care. 2015 Jun 12;19:243. doi: 10.1186/s13054-015-0961-2.
PMID: 26067660BACKGROUNDSelig HF, Lumenta DB, Giretzlehner M, Jeschke MG, Upton D, Kamolz LP. The properties of an "ideal" burn wound dressing--what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. Burns. 2012 Nov;38(7):960-6. doi: 10.1016/j.burns.2012.04.007. Epub 2012 May 8.
PMID: 22571855BACKGROUNDSerrano C, Boloix-Tortosa R, Gomez-Cia T, Acha B. Features identification for automatic burn classification. Burns. 2015 Dec;41(8):1883-1890. doi: 10.1016/j.burns.2015.05.011. Epub 2015 Jul 15.
PMID: 26188898BACKGROUNDWasiak J, Cleland H, Campbell F, Spinks A. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD002106. doi: 10.1002/14651858.CD002106.pub4.
PMID: 23543513BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wawaimuli Arozal, MD, PhD
Indonesia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The person that assess the degree of epithelization will be presented with photos of the burn conditions and will not be given information of the patient's treatment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Trial Director
Study Record Dates
First Submitted
June 12, 2017
First Posted
June 19, 2017
Study Start
March 1, 2017
Primary Completion
March 5, 2018
Study Completion
March 5, 2018
Last Updated
March 12, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share